January 2026: Healthcare M&A Snapshot
- Eclipse Corporate Finance
- 8 hours ago
- 2 min read

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in January 2026 below.
Notable Sector Deals: January 2026
LDC’s investment into myHappymind
myHappymind, a leading digital mental health and wellbeing programme for schools, has secured a minority investment from LDC
Founded in 2017, the business delivers interactive mental health content to over 1,900 schools across the UK
The business has grown rapidly in recent years, driven by increasing demand for preventative mental health support in schools
LDC’s investment will support expansion into more schools in the UK and internationally, alongside ongoing product development
The deal highlights strong M&A and investment activity in preventative mental health services
Acquisition of Care Quality Pharmacy by Pharmacy2U
Pharmacy2U has acquired Care Quality Pharmacy, a specialist pharmacy provider focused on supporting care homes and residential care settings
Pharmacy2U is the UK’s largest online pharmacy, serving millions of NHS patients through digital prescription management, dispensing and delivery
The acquisition represents a strategic move by Pharmacy2U into the care home pharmacy segment, broadening its exposure beyond consumer-facing distance-selling services
The deal reflects ongoing consolidation within pharmacy services as scaled operators seek to diversify revenue streams and deploy technology effectively
Rockpool’s investment into Carescribe
Rockpool has invested in CareScribe, a rapidly growing assistive technology company focused on improving accessibility, productivity and inclusivity for disabled and neurodivergent people in education and the workplace.
CareScribe offers software tools including Caption.Ed, TalkType and Medincle to support independent working and studying
The investment will support CareScribe’s next phase of growth: scaling product‑led user adoption, expanding its software portfolio, and accelerating growth across workplace and education markets
The deal underscores strong investor appetite for scalable technology platforms addressing the needs of disabled and neurodivergent individuals
Mayden’s acquisition of ClinicLetter.ai
ClinicLetter.ai (CLAI), an ambient scribe solution built for the NHS, has joined G Square-backed Mayden to expand digital support for clinicians.
CLAI uses Ambient Voice Technology to reduce manual data entry and has demonstrated up to a 30% reduction in administrative workload
The addition strengthens Mayden’s mission to transform health and care by expanding its digital offering across the NHS, local authorities, VCSEs and the private sector
CLAI will sit alongside Mayden’s existing products (iaptus, theseus and bacpac), broadening support for clinical services
Healthcare Market Activity: January 2026
Private Equity Activity
Sub-sector | Target | Acquirer / Investor | Exiting PE |
Digital Health | Carescribe | Rockpool | N/A |
Digital Health | Mayden (G Square) | N/A | |
Digital Health | PPD | Agilio (Five Arrows) | N/A |
Elderly Care | 3 x homes in Scotland | Care Concern (Downing) | N/A |
Medical Equipment | Derbyshire Mobility | Eden Mobility (Foresight) | N/A |
Medical Equipment | Iskus Health UK | Fannin UK (Invest Industrial) | N/A |
Medical Equipment | Medguard Equipment | Mediq (Advent) | N/A |
Mental Health | MyHappyMind | LDC | N/A |
Pharmacy | Care Quality Pharmacy | Pharmacy2U (G Square) | N/A |
Pharma Services | Bridge Medical Consulting | Red Nucleus (THL) | N/A |
Pharma Services | Uptake | Prescient (Bridgepoint) | N/A |
Specialist Care | Awelon Healthcare | Iris Care (Ancala) | N/A |
Training | Caring For Care | Impact Futures (August) | N/A |
Venture Capital Activity
Target | Description | Lead Investor | Investment |
Emerald | Proactive healthcare platform that unifies health data, AI insights, and GP-led care | Boost Capital Partners | $2m |
Eolas Medical | Provides AI-powered clinical knowledge tools | Acton Capital | $12m |
Evaro | Embeddable digital pharmacy infrastructure and prescribing tools | Albion VC | $25m |
Nuclera | Antibody engineering | Elevage Medical Technologies | $12m |
